ATE243024T1 - Zusammensetzung zur kontrollierten freisetzung - Google Patents

Zusammensetzung zur kontrollierten freisetzung

Info

Publication number
ATE243024T1
ATE243024T1 AT98900793T AT98900793T ATE243024T1 AT E243024 T1 ATE243024 T1 AT E243024T1 AT 98900793 T AT98900793 T AT 98900793T AT 98900793 T AT98900793 T AT 98900793T AT E243024 T1 ATE243024 T1 AT E243024T1
Authority
AT
Austria
Prior art keywords
controlled release
composition
release composition
active material
biologically active
Prior art date
Application number
AT98900793T
Other languages
German (de)
English (en)
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Niels Krog
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Application granted granted Critical
Publication of ATE243024T1 publication Critical patent/ATE243024T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98900793T 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung ATE243024T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition

Publications (1)

Publication Number Publication Date
ATE243024T1 true ATE243024T1 (de) 2003-07-15

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900793T ATE243024T1 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung

Country Status (9)

Country Link
US (1) US6660278B1 (https=)
EP (1) EP0954287B1 (https=)
JP (1) JP2001508773A (https=)
AT (1) ATE243024T1 (https=)
AU (1) AU5583298A (https=)
CA (1) CA2277377C (https=)
DE (1) DE69815659T2 (https=)
SE (1) SE511313C2 (https=)
WO (1) WO1998030206A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
ES2561108T3 (es) * 2001-10-19 2016-02-24 Idexx Laboratories, Inc. Composiciones inyectables para la liberación controlada de compuesto farmacológicamente activo
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036984A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Stand-alone film and methods for making the same
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057328A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
WO2010063080A1 (en) 2008-12-05 2010-06-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
WO2011145659A1 (ja) * 2010-05-18 2011-11-24 富士フイルム株式会社 カロチノイド含有組成物及びその製造方法
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
EP3791861A1 (en) 2012-07-26 2021-03-17 Camurus AB Opioid formulations
NZ704012A (en) 2012-07-26 2017-09-29 Camurus Ab Opioid formulations
BR112020010519A2 (pt) 2017-11-27 2020-10-20 Umecrine Cognition Ab formulação farmacêutica de oxima de 3¿lfa-etinil-3¿eta-hidroxiandrostan-17-ona
WO2019204869A1 (en) 2018-04-26 2019-10-31 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
SG11202107877WA (en) 2018-06-21 2021-08-30 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
JP7646013B2 (ja) * 2021-01-29 2025-03-14 イーオーイー オレオ ゲーエムベーハー ポリグリセロール脂肪酸エステル含有組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (https=) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
AU668509B2 (en) * 1991-04-19 1996-05-09 Affinity Biotech, Inc. Convertible microemulsion formulations
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
SE9700061L (sv) 1998-07-14
AU5583298A (en) 1998-08-03
DE69815659D1 (de) 2003-07-24
EP0954287B1 (en) 2003-06-18
SE9700061D0 (sv) 1997-01-13
US6660278B1 (en) 2003-12-09
DE69815659T2 (de) 2004-04-29
JP2001508773A (ja) 2001-07-03
EP0954287A1 (en) 1999-11-10
SE511313C2 (sv) 1999-09-06
CA2277377C (en) 2007-12-18
CA2277377A1 (en) 1998-07-16
WO1998030206A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
DE69815659D1 (de) Zusammensetzung zur kontrollierten freisetzung
ES2153355T3 (es) Procedimiento para la preparacion de microesferas que contienen compuestos biologicamente activos.
TR199701277T1 (xx) Biyoaktif bile�ikler olarak ya� asidi esterleri.
DE69836491D1 (de) Fibrinmikrokugeln und deren verwendungen
HUP0000937A2 (hu) Új zsírsav-származékok
DK0549774T3 (da) Anvendelse af porøst calciumcarbonat som bærermateriale for in vitro cellekulturer
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
EP1224940A8 (de) Flüssige Interferon-Beta Formulierungen
AU561811B2 (en) Organic amide compounds derived from nitrogenous lipids
EP0152281A3 (en) Transdermal formulation of nicardipine hydrochloride
BR9808668A (pt) Suspensão aquosa de microcápsulas compreendendo um material biologicamente ativo, e, processos para preparação de uma suspensão aquosa de microcápsulas aderentes e para aplicação de microcápsulas em um substrato pretendido
MY110984A (en) Immobilized lipases
DE69531864D1 (de) Indolizin spal2 inhibitoren
EP0681846A3 (en) Cell culture products.
NO970317D0 (no) Anvendelse av DHA i en farmasöytisk blanding
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
ITMI931326A1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
AU1911999A (en) Methods and compositions for treating diabetes
CA2263557A1 (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
AU1576092A (en) Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
JPS57117868A (en) Method of combining biological active substance to carrier containing hydroxyl group
DE59708441D1 (de) Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
YU47192A (sh) Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje
AU4836497A (en) Enhancing keratinocyte migration and proliferation
GB2324528A (en) Cytostatic hydroxamic acid derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties